Elodie Person

Elodie Person

Auto-generated profile, based on publicly available information

Elodie Person

University of Toulouse, EI PURPAN, ENVT, INRAE, TOXALIM, Toulouse, France

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2022 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
AHAmanda Lopes Hasuda
Amanda Lopes Hasuda
EPElodie Person
Elodie Person
AKAbdullah Khan Khoshal
Abdullah Khan Khoshal
SBSandrine Bruel
Sandrine Bruel
SPSylvie Puel
Sylvie Puel
PPPhilippe PINTON
Philippe PINTON

21 October 2018 in Journal of Applied Toxicology
Verified
Journal Article
Open access
PDF file
CGC. Géniès
C. Géniès
EJE. L. Jamin
E. L. Jamin
LDL. Debrauwer
L. Debrauwer
DZD. Zalko
D. Zalko
EPE. N. Person
E. N. Person
CJC. Jacques‐Jamin
C. Jacques‐Jamin
Skin metabolism is important to consider when assessing local toxicity and/or penetration of chemicals and their metabolites. If human skin supply is limited, pig skin can be used as an alternative. To identify any species differences, we have investigated the metabolism of 10 chemicals in a pig and human skin explant model. Phase I metabolic pathways in skin from both species included those known to occur via cytochrome P450s, esterases, alcohol dehydrogenases and aldehyde dehydrogenases. Common Phase II pathways were glucuronidation and sulfation but other conjugation pathways were also identified. Chemicals not metabolized by pig skin (caffeine, IQ and 4‐chloroaniline) were also not metabolized by human skin. Six chemicals metabolized by pig skin were metabolized to a similar extent (percentage parent remaining) by human skin. Human skin metabolites were also detected in pig skin incubations, except for one unidentified minor vanillin metabolite. Three cinnamyl alcohol metabolites were unique to pig skin but represented minor metabolites. There were notable species differences in the relative amounts of common metabolites. The difference in the abundance of the sulfate conjugates of resorcinol and 4‐amino‐3‐nitrophenol was in accordance with the known lack of aryl sulfotransferase activity in pigs. In conclusion, while qualitative comparisons of metabolic profiles were consistent between pig and human skin, there were some quantitative differences in the percentage of metabolites formed. This preliminary assessment suggests that pig skin is metabolically competent and could be a useful tool for evaluating potential first‐pass metabolism before testing in human‐derived tissues.

13 June 2023 in Toxicon
Verified
Journal Article
Closed access
AHAmanda Lopes Hasuda
Amanda Lopes Hasuda
EPElodie Person
Elodie Person
Abdullah KHOSHALAbdullah KHOSHAL
Abdullah KHOSHAL
SBSandrine Bruel
Sandrine Bruel
SPSylvie Puel
Sylvie Puel
PPPhilippe PINTON
Philippe PINTON

19 November 2018 in Journal of Proteome Research
Verified
Journal Article
Closed access
NPNathalie Poupin
Nathalie Poupin
ACAnne Corlu
Anne Corlu
NCNicolas J. Cabaton
Nicolas J. Cabaton
HDHélène Dubois-Pot-Schneider
Hélène Dubois-Pot-Schneider
CCCécile Canlet
Cécile Canlet
Fabien JourdanFabien Jourdan
Fabien Jourdan

9 October 2025 in Toxicology
Verified
Journal Article
Open access
EPElodie Person
Elodie Person
NCNicolas J. Cabaton
Nicolas J. Cabaton
LULaurie Urien
Laurie Urien
MLMarlène Z. Lacroix
Marlène Z. Lacroix
Jorke KamstraJorke Kamstra
Jorke Kamstra
DZDaniel Zalko
Daniel Zalko
Metabolism disrupting chemicals (MDCs) are a class of endocrine disrupting substances that promote metabolic changes leading to metabolic disorders in humans. Central to assessing their adverse effects is the need to better understand their modes of action (MoA). Cytochrome P450 (CYP) enzymes play a major role in xenobiotic metabolism, but also catalyse many endogenous metabolic reactions. Therefore, modulation of CYP functionality may impact homeostasis, contributing to adverse outcomes. At the functional level, alteration of the activity of human CYPs by MDCs largely remains unexplored. In this study we investigated the capability of six candidate MDCs, bisphenol A (BPA), perfluorooctanoic acid (PFOA), tributyltin (TBT), dichlorodiphenyldichloroethylene (p,p'-DDE), triclosan (TCS) and triphenylphosphate (TPP) to induce CYP1A2, CYP2B6 and CYP3A4 activities in the human hepatic HepaRG cell line. The CYP induction test method previously validated for pharmaceuticals was optimised and selected MDCs were tested in the context of the European Horizon 2020 GOLIATH project. Induction was revealed using a cocktail of CYP-selective probe substrates, followed by probe metabolite quantification by mass spectrometry. All MDCs except TCS induced CYP activities. PFOA, TBT, p,p'-DDE and TPP induced CYP1A2, TPP being the most potent inducer. BPA, PFOA, TBT and TPP induced CYP2B6, PFOA being the most potent inducer. BPA, PFOA, TBT, p,p'-DDE and TPP all induced CYP3A4, p,p'-DDE and BPA being the most potent inducers. These results highlight the capability of candidate MDCs to induce key CYP activities in a human relevant hepatic model, paving the way for a better understanding of MDCs mechanisms of action.

13 March 2026 in Environment International
Verified
Journal Article
Open access
OTOlha Tsykhotska
Olha Tsykhotska
MVMarine Valleix
Marine Valleix
SBSandrine Bruel
Sandrine Bruel
AHAnne Hillenweck
Anne Hillenweck
LULaurie Urien
Laurie Urien
DZDaniel Zalko
Daniel Zalko
For 50 years, bisphenol A (BPA) has been extensively used as a colour developer in thermal printing papers. The European Union and several other countries have drastically restricted BPA's use in thermal paper, due to its endocrine-disrupting properties. Consequently, bisphenol S (BPS) and Pergafast 201 (PF201) are increasingly used as substitutes, despite their percutaneous absorption remains poorly documented. We conducted an ex vivo study to achieve a comparative assessment of the skin absorption and metabolism of BPA, BPS and PF201. Tritium-labelled compounds were topically applied to viable human skin explants mounted on static Franz diffusion cells, providing complete mass-balance data compliant with OECD recommendations (n° 428, 28, 156). Absorbed doses were 5.1 ± 2.4 % for BPA, and below 1 % for BPS and PF201 (BPA > BPS ∼ PF201). Dermal delivery reached 16.1 ± 3.5 % for BPA, 8.7 ± 4.2 % for BPS and 3.5 ± 1.3 % for PF201 (BPA > BPS > PF201). Additional experiments were conducted for PF201 at five different doses (7.8-638.5 ng/cm2) to determine skin permeation parameters. PF201's absorbed dose and dermal delivery remained constant, its permeability coefficient was found to range between 0.63 and 2.0 × 10⁻⁶ cm/h, and its flux between 0.75 and 84.0 × 10⁻3 ng/cm2/h. No PF201 metabolism or degradation were observed in skin explants. Our results demonstrate that despite limited absorption, PF201 remains in the skin after 24 h, suggesting prolonged bioavailability. This study closes major knowledge gaps related to the absorption and metabolism of PF201 through viable human skin and provides useful data for improved risk assessment.